|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
V
3 contains a receptor site for resveratrol
E-mail contact: fdavis@ordwayresearch.org
Resveratrol is a naturally occurring polyphenol, which causes apoptosis in cultured cancer cells. We describe a cell surface resveratrol receptor on the extracellular domain of hetero-dimeric
V
3 integrin in MCF-7 human breast cancer cells. This receptor is linked to induction by resveratrol of extracellular-regulated kinases 1 and 2 (ERK1/2)- and serine-15-p53-dependent phosphorylation leading to apoptosis. The integrin receptor is near the Arg-Gly-Asp (RGD) recognition site on the integrin; an integrin-binding RGD peptide inhibits induction by resveratrol of ERK1/2- and p53-dependent apoptosis. Antibody (Ab) to integrin
V
3, but not to
V
5, inhibits activation by resveratrol of ERK1/2 and p53 and consequent apoptosis in estrogen receptor-
(ER
) positive MCF-7, and ER
-negative MDA-MB231 cells. Resveratrol is displaced from the purified integrin by an RGD, but not RGE, peptide, and by
V
3 integrin-specific Ab. Resveratrol action is blocked by siRNA
3, but not by siRNA
V. [14C]-Resveratrol binds to commercially purified integrin
V
3 and to
V
3 prepared from MCF-7 cells; binding of [14C]-resveratrol to the
3, but not to the
V monomer, is displaced by unlabeled resveratrol. In conclusion, binding of resveratrol to integrin
V
3, principally to the
3 monomer, is essential for transduction of the stilbene signal into p53-dependent apoptosis of breast cancer cells.--Lin, H.-Y., Lansing, L., Merillon, J.-M., Davis, F. B., Tang, H.-Y., Shih, A., Vitrac, X., Krisa, S., Keating, T., Cao, H. J., Bergh, J., Quackenbush, S., Davis, P. J. Integrin
V
3 contains a receptor site for resveratrol.
This article has been cited by other articles:
![]() |
H.-Y. Lin, H.-Y. Tang, T. Keating, Y.-H. Wu, A. Shih, D. Hammond, M. Sun, A. Hercbergs, F. B. Davis, and P. J. Davis Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated Carcinogenesis, January 1, 2008; 29(1): 62 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sareen, S. R. Darjatmoko, D. M. Albert, and A. S. Polans Mitochondria, Calcium, and Calpain are Key Mediators of Resveratrol-Induced Apoptosis in Breast Cancer Mol. Pharmacol., December 1, 2007; 72(6): 1466 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Heiss, Y. D. C. Schilder, and V. M. Dirsch Chronic Treatment with Resveratrol Induces Redox Stress- and Ataxia Telangiectasia-mutated (ATM)-dependent Senescence in p53-positive Cancer Cells J. Biol. Chem., September 14, 2007; 282(37): 26759 - 26766. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. van Ginkel, D. Sareen, L. Subramanian, Q. Walker, S. R. Darjatmoko, M. J. Lindstrom, A. Kulkarni, D. M. Albert, and A. S. Polans Resveratrol Inhibits Tumor Growth of Human Neuroblastoma and Mediates Apoptosis by Directly Targeting Mitochondria Clin. Cancer Res., September 1, 2007; 13(17): 5162 - 5169. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |